To explore the clinical significance of IRF4-mediated differentiation of PMN-MDSCs, peripheral blood samples from patients with liver cancer (HCC) were collected, and peripheral blood samples from nontumor patients with liver fibrosis served as controls. The gene discussed is IRF4; the disease is hepatocellular carcinoma.